
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari
Springer eBooks (2016), pp. 107-120
Closed Access | Times Cited: 25
Rudolph M. Navari
Springer eBooks (2016), pp. 107-120
Closed Access | Times Cited: 25
Showing 25 citing articles:
NCCN Guidelines Insights: Antiemesis, Version 2.2017
Michael Berger, David S. Ettinger, J N Aston, et al.
Journal of the National Comprehensive Cancer Network (2017) Vol. 15, Iss. 7, pp. 883-893
Open Access | Times Cited: 215
Michael Berger, David S. Ettinger, J N Aston, et al.
Journal of the National Comprehensive Cancer Network (2017) Vol. 15, Iss. 7, pp. 883-893
Open Access | Times Cited: 215
Sonodynamic therapy of pancreatic cancer cells based on synergistic chemotherapeutic effects of selenium-PEG-curcumin nanoparticles and gemcitabine
Shahrzad Ilbeigi, Aliyeh Ranjbar, N. Zahraie, et al.
Applied Physics A (2023) Vol. 129, Iss. 2
Closed Access | Times Cited: 8
Shahrzad Ilbeigi, Aliyeh Ranjbar, N. Zahraie, et al.
Applied Physics A (2023) Vol. 129, Iss. 2
Closed Access | Times Cited: 8
Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic Chemotherapy
Ciara C. O’Sullivan, Holly K. Van Houten, Lindsey R. Sangaralingham, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 294-299
Open Access | Times Cited: 15
Ciara C. O’Sullivan, Holly K. Van Houten, Lindsey R. Sangaralingham, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 294-299
Open Access | Times Cited: 15
Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology
Rupert Bartsch, Daniel Aletaha, Thorsten Fuereder, et al.
Journal of Geriatric Oncology (2024), pp. 102077-102077
Closed Access | Times Cited: 1
Rupert Bartsch, Daniel Aletaha, Thorsten Fuereder, et al.
Journal of Geriatric Oncology (2024), pp. 102077-102077
Closed Access | Times Cited: 1
Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting
Bernardo L. Rapoport
Cancer Management and Research (2017) Vol. Volume 9, pp. 41-50
Open Access | Times Cited: 8
Bernardo L. Rapoport
Cancer Management and Research (2017) Vol. Volume 9, pp. 41-50
Open Access | Times Cited: 8
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide–based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial
Ian D. Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Cancer Management and Research (2017) Vol. Volume 9, pp. 179-187
Open Access | Times Cited: 8
Ian D. Schnadig, Richy Agajanian, Christopher Dakhil, et al.
Cancer Management and Research (2017) Vol. Volume 9, pp. 179-187
Open Access | Times Cited: 8
Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
Noha Rashad, Omar Abdel‐Rahman
Drug Design Development and Therapy (2017) Vol. Volume11, pp. 947-954
Open Access | Times Cited: 7
Noha Rashad, Omar Abdel‐Rahman
Drug Design Development and Therapy (2017) Vol. Volume11, pp. 947-954
Open Access | Times Cited: 7
Phase II study of pregabalin for the prevention of chemotherapy induced nausea and vomiting
Carla Santos Rossi Paniquar, Auro del Giglio, Alayne Magalhães Trindade Domingues Yamada, et al.
O Mundo da Saúde (2024) Vol. 48
Open Access
Carla Santos Rossi Paniquar, Auro del Giglio, Alayne Magalhães Trindade Domingues Yamada, et al.
O Mundo da Saúde (2024) Vol. 48
Open Access
Estudo de fase II de pregabalina para prevenção de náuseas e vômitos induzidos por quimioterapia
Carla Santos Rossi Paniquar, Auro del Giglio, Alayne Magalhães Trindade Domingues Yamada, et al.
O Mundo da Saúde (2024) Vol. 48
Open Access
Carla Santos Rossi Paniquar, Auro del Giglio, Alayne Magalhães Trindade Domingues Yamada, et al.
O Mundo da Saúde (2024) Vol. 48
Open Access
Optimal Management of Chemotherapy-related Adverse Events
Min Kyu Jung
The Korean Journal of Pancreas and Biliary Tract (2020) Vol. 25, Iss. 1, pp. 46-54
Open Access | Times Cited: 2
Min Kyu Jung
The Korean Journal of Pancreas and Biliary Tract (2020) Vol. 25, Iss. 1, pp. 46-54
Open Access | Times Cited: 2
Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial
Akimitsu Maeda, Hiroki Yoshida, Hirotaka Inoue, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 3, pp. 2699-2708
Open Access | Times Cited: 2
Akimitsu Maeda, Hiroki Yoshida, Hirotaka Inoue, et al.
Annals of Palliative Medicine (2021) Vol. 10, Iss. 3, pp. 2699-2708
Open Access | Times Cited: 2
OLANZAPINE VERSUS APREPITANT IN PATIENTS RECEIVING HIGH-EMETOGENIC CHEMOTHERAPY: INTERIM ANALYSIS OF RANDOMIZED PHASE II TRIAL
A. А. Rumyantsev, Elena Glazkova, R. Yu. Nasyrova, et al.
Practical oncology (2018) Vol. 19, Iss. 4, pp. 419-427
Open Access | Times Cited: 1
A. А. Rumyantsev, Elena Glazkova, R. Yu. Nasyrova, et al.
Practical oncology (2018) Vol. 19, Iss. 4, pp. 419-427
Open Access | Times Cited: 1
Olanzapine Combined with 5-HT3 RA Plus Dexamethasone for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in High and Moderate Emetogenic Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jianguo Zhou, Lang Huang, Su‐Han Jin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Jianguo Zhou, Lang Huang, Su‐Han Jin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Affordability of aprepitant for cancer patients in routine clinical practice in russia: analysis of government-established database
A. А. Rumyantsev, Alexandra Tyulyandina, М. Yu. Fedyanin, et al.
Practical oncology (2019) Vol. 20, Iss. 3, pp. 243-252
Open Access | Times Cited: 1
A. А. Rumyantsev, Alexandra Tyulyandina, М. Yu. Fedyanin, et al.
Practical oncology (2019) Vol. 20, Iss. 3, pp. 243-252
Open Access | Times Cited: 1
Distinct issues of palliative care in oncology: prophylaxis and treatment of nausea and vomiting, algorithms of pain management
R.A. Rianzhina, M.V. Skriabin, В. Моисеенко, et al.
Practical oncology (2023) Vol. 24, Iss. 3, pp. 236-263
Open Access
R.A. Rianzhina, M.V. Skriabin, В. Моисеенко, et al.
Practical oncology (2023) Vol. 24, Iss. 3, pp. 236-263
Open Access
Glioblastoma
Dipsanu Paul, Dharmeswar Barhoi
Advances in bioinformatics and biomedical engineering book series (2023), pp. 261-279
Closed Access
Dipsanu Paul, Dharmeswar Barhoi
Advances in bioinformatics and biomedical engineering book series (2023), pp. 261-279
Closed Access
OLANZAPINE FOR NAUSEA AND VOMITING IN VARIOUS ETIOLOGIES : A REVIEW
Nabila Aulia Yasmin Kuswandi, Yulistiani Yulistiani
Pharmaceutical Journal of Indonesia (2023) Vol. 8, Iss. 2, pp. 103-114
Open Access
Nabila Aulia Yasmin Kuswandi, Yulistiani Yulistiani
Pharmaceutical Journal of Indonesia (2023) Vol. 8, Iss. 2, pp. 103-114
Open Access
การศึกษาประสิทธิภาพของโอแลนซาปีนในการควบคุมอาการคลื่นไส้อาเจียนในผู้ป่วยที่ได้รับเคมีบำบัดสูตรที่ทำให้คลื่นไส้และอาเจียนในขนาดสูง (แอนทราไซคลินคู่กับไซโคลฟอสฟาไมด์หรือซิสพลาตินขนาดสูง) โดยใช้โอแลนซาปีนร่วมกับเดกซาเมททาโซนและออนแดนซีทรอนเปรียบเทียบกับยาหลอกร่วมกับเดกซาเมททาโซนและออนแดนซีทรอน
วีริศา วิมลเฉลา
(2017)
Open Access
วีริศา วิมลเฉลา
(2017)
Open Access
การศึกษาต้นทุนประสิทธิผลของการใช้ยาออนแดนซีทรอนร่วมกับโอแลนซาปีนและเดกซาเมททาโซนเปรียบเทียบกับยาเนทตูพิแทน พาลาโนซีตรอน โอแลนซาปีนและเดกซาเมททาโซนในการป้องกันอาการคลื่นไส้อาเจียนในผู้ป่วยที่ได้เคมีบำบัดสูตรที่มีความเสี่ยงคลื่นไส้อาเจียนสูง
วรรศมล มหาพรรณ
(2019)
Open Access
วรรศมล มหาพรรณ
(2019)
Open Access
การศึกษาเปรียบเทียบประสิทธิภาพและความปลอดภัยของยาแก้คลื่นไส้อาเจียนสูตรที่มีนิวทูพิแทนเป็นส่วนประกอบ (ยานิวทูพิแทน ยาพาโลโนซีตรอน ยาโอแลนซาปีนและยาเดกซาเมททาโซน) ในการควบคุมอาการคลื่นไส้อาเจียนในผู้ป่วยทีได้รับยาเคมีบําบัดสูตรซิสพลาตินขนาดสูง กับยาสูตรมาตรฐานใหม่ (ยาออนแดนซีตรอน ยาโอแลนซาปีนและยาเดกซาเมททาโซน)
เฉลิมชัย เลิศอนันต์สิทธิ์
(2019)
Open Access
เฉลิมชัย เลิศอนันต์สิทธิ์
(2019)
Open Access
Evaluation of pre-chemotherapy antiemetic prescriptions in a hospital unit
Andressa B. Souza, Benedito Carlos Cordeiro
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde (2020) Vol. 10, Iss. 3, pp. 341-341
Open Access
Andressa B. Souza, Benedito Carlos Cordeiro
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde (2020) Vol. 10, Iss. 3, pp. 341-341
Open Access
Cost-utility analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapy
Yu Kondo, Tomoya Tachi, Takayoshi Sakakibara, et al.
Research Square (Research Square) (2021)
Open Access
Yu Kondo, Tomoya Tachi, Takayoshi Sakakibara, et al.
Research Square (Research Square) (2021)
Open Access